Efficacy and safety of once-weekly semaglutide for the treatment of type 2 diabetes: Protocol for a systematic review and meta-analysis

BACKGROUND: It is a great challenge for type 2 diabetes mellitus (T2DM) patients to maintain optimal glycemia, control body weight, blood pressure, and avoiding hypoglycemia. Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1 RAs) can stimulate glucose-dependent insulin while inhibit glucagon...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Fang-Hong, Li, Hao, Cui, Min, Zhang, Zai-Li, Gu, Zhi-Chun, Liu, Xiao-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916683/
https://www.ncbi.nlm.nih.gov/pubmed/29668601
http://dx.doi.org/10.1097/MD.0000000000010420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916683/
https://www.ncbi.nlm.nih.gov/pubmed/29668601
http://dx.doi.org/10.1097/MD.0000000000010420

Ejemplares similares